Jupiter Topco LLC Acquires New Position in GRAIL, Inc. $GRAL

Jupiter Topco LLC acquired a new stake in GRAIL, Inc. (NASDAQ:GRAL) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 16,000 shares of the company’s stock, valued at approximately $1,091,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in GRAL. Parallel Advisors LLC grew its holdings in shares of GRAIL by 5.2% during the 4th quarter. Parallel Advisors LLC now owns 2,667 shares of the company’s stock valued at $228,000 after acquiring an additional 133 shares in the last quarter. Comerica Bank raised its holdings in shares of GRAIL by 59.2% during the third quarter. Comerica Bank now owns 465 shares of the company’s stock worth $27,000 after acquiring an additional 173 shares in the last quarter. Prosperity Consulting Group LLC raised its holdings in shares of GRAIL by 6.9% during the first quarter. Prosperity Consulting Group LLC now owns 3,881 shares of the company’s stock worth $201,000 after acquiring an additional 250 shares in the last quarter. Rossby Financial LCC boosted its position in GRAIL by 25.0% during the fourth quarter. Rossby Financial LCC now owns 1,250 shares of the company’s stock valued at $107,000 after purchasing an additional 250 shares during the last quarter. Finally, Blair William & Co. IL boosted its position in GRAIL by 5.3% during the third quarter. Blair William & Co. IL now owns 5,356 shares of the company’s stock valued at $317,000 after purchasing an additional 268 shares during the last quarter.

GRAIL Price Performance

NASDAQ GRAL opened at $80.34 on Friday. GRAIL, Inc. has a fifty-two week low of $33.61 and a fifty-two week high of $118.84. The stock’s 50-day moving average is $72.54 and its two-hundred day moving average is $62.97. The firm has a market cap of $3.59 billion, a P/E ratio of -8.24 and a beta of 3.25.

GRAIL (NASDAQ:GRAL) last issued its quarterly earnings data on Wednesday, August 5th. The company reported ($2.56) EPS for the quarter, beating analysts’ consensus estimates of ($2.66) by $0.10. GRAIL had a negative return on equity of 15.88% and a negative net margin of 236.95%.The business had revenue of $44.69 million for the quarter, compared to analyst estimates of $42.39 million. On average, equities analysts expect that GRAIL, Inc. will post -10.41 EPS for the current year.

Insider Buying and Selling at GRAIL

In other GRAIL news, CFO Aaron Freidin sold 7,900 shares of the company’s stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $85.01, for a total transaction of $671,579.00. Following the completion of the sale, the chief financial officer directly owned 253,083 shares in the company, valued at $21,514,585.83. This represents a 3.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Joshua J. Ofman sold 5,000 shares of the firm’s stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $85.02, for a total value of $425,100.00. Following the completion of the sale, the chief executive officer directly owned 397,271 shares in the company, valued at approximately $33,775,980.42. This represents a 1.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.83% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

GRAL has been the topic of several research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of GRAIL in a research report on Friday, July 17th. Wolfe Research started coverage on GRAIL in a report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Wall Street Zen cut GRAIL from a “hold” rating to a “sell” rating in a research note on Saturday. Mizuho increased their price objective on GRAIL from $58.00 to $65.00 and gave the stock a “neutral” rating in a report on Wednesday, July 15th. Finally, The Goldman Sachs Group initiated coverage on shares of GRAIL in a research report on Friday, June 5th. They set a “neutral” rating and a $60.00 price objective on the stock. Four analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, GRAIL currently has a consensus rating of “Hold” and a consensus price target of $67.78.

GRAIL Profile

GRAIL, Inc (NASDAQ: GRAL) is a biotechnology company dedicated to the early detection of cancer through a multi-cancer blood test. Leveraging advances in next-generation sequencing, cell-free DNA (cfDNA) analysis and machine learning, GRAIL has developed the Galleri™ test, which aims to identify more than 50 types of cancer at their earliest stages. The company’s platform analyzes methylation patterns in circulating tumor DNA to pinpoint tumor presence and tissue of origin, enabling physicians to pursue timely diagnostic follow-up.

Founded in 2016 as a spin-out from Illumina, GRAIL established its headquarters in Menlo Park, California, with additional research and operations centers in the United Kingdom.